Acceptability and Tolerance Study of a High Energy Tube Feed with Food Derived Ingredients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-24

Study Completion Date

2023-12-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Enterally fed adults and children who are assessed by the dietitian as requiring an adult high-energy, fibre-containing enteral formula will be recruited. Data from 15 participants are required in order to submit an application to the Advisory Committee on Borderline Substances (ACBS) for product registration.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends

NCT07341464

Cerebral Palsy (CP) Oncology

RECRUITING NA

Nutritional Tolerance and Safety of a Tube Feeding Formula

NCT05848583

Enteral Feeding

TERMINATED NA

A Single Arm Intervention Study to Assess the Acceptability, Tolerance and Ease of Use of Wilbo's Blends+ (Commercial Enteral Feed Based on Real Food) When Used as Part of a Dietitian Prescribed Enteral Feeding Plan

NCT07036081

Enteral Nutrition (Food for Special Medical Purposes) Enteral Feeds Enteral Tube Nutrition +1 more

RECRUITING NA

Efficacy and Safety of Lanreotide 120 Milligram (mg) as a Palliative Treatment of Clinical Symptoms Associated With Malignant Intestinal Obstruction in Inoperable Patients

NCT01076803

Malignant Intestinal Obstruction

COMPLETED PHASE2

Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial

NCT02784392

Enteral Feeding Intolerance (EFI)

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To evaluate the acceptability (including gastrointestinal tolerance and compliance) of a high energy, adult enteral formula with food-derived ingredients.This is a single arm, prospective, multi-centre study to evaluate the gastrointestinal tolerance and compliance over a 14-day period with the new tube feed.

Participants or their caregivers will be provided with 14-day supply of the new tube feed and will be asked to complete a daily diary and short questionnaire to record information allowing assessment of the following:

* Gastrointestinal tolerance
* Compliance with prescribed feed volume

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tolerance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients well established on tube feeds will act as their own control

These patients will switch from current to new tube feed to assess acceptability and tolerance

Group Type OTHER

Compleat 1.5 HP

Intervention Type DIETARY_SUPPLEMENT

Patients well established and stable on an enteral tube feed. This group will act as their own controls and switched to the new tube feed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Compleat 1.5 HP

Patients well established and stable on an enteral tube feed. This group will act as their own controls and switched to the new tube feed.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients requiring an enteral tube feed (taking \> 60% of energy needs from their feeding tube) as part of their dietary management for disease related malnutrition

* Children 15 years and over
* Adults and children requiring an adult high-energy and fibre-containing formula, as assessed by the dietitian.
* Patients well-established and stable on enteral feeding.
* Willingly given, written, informed consent from patient or consultee
* Willingly given, written assent (if appropriate).

Exclusion Criteria

* Inability to comply with the study protocol, in the opinion of the investigator

* Children under 15 years of age
* Patients receiving mechanical ventilation, sedation or inotropic support
* Patients on total parenteral nutrition
* Known food allergies to any ingredients (see ingredients list) or galactosaemia
* Patients with significant renal or hepatic impairment
* Patients with planned changes to medication or treatments during the study period which may alter gastrointestinal function (e.g. chemotherapy). Changes in medications or nutritional products during the study intervention must be documented.
* Participation in another interventional study within 2 weeks of this study.
* Patients with a clinical indication for a low fibre or fibre free diet as advised by the healthcare team.
* Patients with known or suspected ileus or mechanical bowel obstruction

Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No